Académique Documents
Professionnel Documents
Culture Documents
LORCASERINA
REFERENCIAS
Steven R. Smith, M.D., Weissman, M.D., Christen M. Anderson, M.D.,
Ph.D., Matilde Sanchez, Ph.D., Emil Chuang, M.D., Scott Stubbe, M.B.A.,
Harold Bays, M.D., William R. Shanahan, M.D., Multicenter, placebo-
controlled trial of lorcaserin for weight management and the Behavioral
Modification and Lorcaserin for Overweight and Obesity Management
(BLOOM) Study Group N Eng J Med 2010;363;24556.
W. Philip T. James, M.D., D.Sc., Ian D. Caterson, M.D., Ph.D., Walmir
Coutinho, M.D., D.Sc., Nick Finer, M.B., B.S., Luc F. Van Gaal, M.D.,
Ph.D., Aldo P. Maggioni, M.D., Christian Torp-Pedersen, M.D., Ph.D.,
Arya M. Sharma, M.D., Ph.D., Gillian M. Shepherd, B.Sc., Richard A.
Rode, Ph.D., and Cheryl L. Renz, M.D., for the SCOUT Investigators.
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and
Obese Subjects. N Engl J Med 2010; 363:905-917.